Skip to main content

AUPH

Stock

AUPH

Stock
Health Care
Biotechnology

Performance overview

AUPH Price
Price Chart

Forward-looking statistics

Beta
0.81
Risk
48.45%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, canada.

Company info

SectorHealth Care
IndustryBiotechnology
Employees318
Market cap$758.0M

Fundamentals

Enterprise value$909.7M
Revenue$247.3M
Revenue per employee
Profit margin16.11%
Debt to equity22.25

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$0.27
Dividend per share
Revenue per share$1.74
Avg trading volume (30 day)$13M
Avg trading volume (10 day)$20M
Put-call ratio

Macro factor sensitivity

Growth+3.7
Credit+32.6
Liquidity-16.2
Inflation-2.1
Commodities+0.8
Interest Rates-1.7

Valuation

Dividend yield0.00%
PEG Ratio14.06
Price to sales4.15
P/E Ratio14.06
Enterprise Value to Revenue3.68
Price to book2.99

Upcoming events

Next earnings dayMay 12, 2025
Next dividend day
Ex. dividend day

News

Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains?

Aurinia (AUPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research (June 27, 2025)
Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance

Aurinia Pharmaceuticals Inc.  AUPH reported first-quarter earnings of 16 cents per share, compared to a loss of 7 cents a year ago. This beat the consensus of 10 cents.

Benzinga (May 12, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free